Betsy Cramer
Primary Care · Coldwater, MINPI 1003656281
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations.
Across 89 payments — averaging $21.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$272
- Otsuka America Pharmaceutical, Inc.$190
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$176
- Viatris Specialty LLC$175
- Amgen$102
- Sanofi-aventis U.S. LLC$100
- plus $879 from 17 others
What the payments were for
- Food & beverage$1,79495%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $272 |
| Otsuka America Pharmaceutical, Inc. | 12 | $190 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $176 |
| Viatris Specialty LLC | 7 | $175 |
| Amgen | 5 | $102 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 5 | $100 |
| Lundbeck LLC | 5 | $98 |
| AbbVie | 6 | $97 |
| Corcept Therapeutics | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| Sanofi | 2 | $63 |
| Bayer | 3 | $56 |
| Novo Nordisk | 2 | $49 |
| Mylan Specialty L.p. | 2 | $48 |
| Exact Sciences | 2 | $47 |
| Genentech USA, Inc. | 1 | $33 |
| Verona Pharma, Inc. | 1 | $31 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
| Alkermes, Inc. | 1 | $28 |
| Novartis | 1 | $26 |
| Lilly USA, LLC | 1 | $20 |
| GSK | 1 | $15 |
How this compares
$1,894 in reported general payments places this provider in the 80th percentile of 292 primary care providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 14 | $292 |
| CefuroximeCefuroxime Axetil | 21 | $273 |
| Losartan Potassium | 16 | $268 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $234 |
| Atorvastatin Calcium | 18 | $189 |
| Prednisone | 41 | $114 |
| Amlodipine Besylate | 14 | $84 |
| Azithromycin | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other primary care in Coldwater
- Melinda PateColdwater$2K
- Donna HamillGrosse Pointe$17K
- Marie Sighe-NzokouLansing$16K
- Alexandria SchwabBay City$10K
- Amy HenryRochester Hills$10K
- Claire GebaraWaterford$9K
- Vanita RobinsonDetroit$9K
- Mary BoudreauMason$9K
- Kimberly FrazierLansing$8K
- Rachel HetznerMadison Heights$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.